العنوان البديل: Amendments to Global Asthma Initiative (GINA) 2019 recommendation - crucial modification of treatment method.

المؤلفون: LIKOŃSKA, ALEKSANDRA¹, KOWALSKI, MAREK L.¹, CHAŁUBIŃSKI, MACIEJ¹

المصدر: Alergia Astma Immunologia. Sep2019, Vol. 24 Issue 3, p112-118. 7p.

مصطلحات موضوعية: *ASTHMA, *FORMOTEROL, *DRUGS

العنوان البديل: Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma.

المؤلفون: Humbert, M.¹, Andersson, T. L. G.², Buhl, R.³

المصدر: Alergia Astma Immunologia. 2008, Vol. 13 Issue 4, p183-196. 14p. 1 Diagram, 1 Chart, 5 Graphs.

مصطلحات موضوعية: *DISEASE management, *FORMOTEROL, *HEALTH risk assessment, *ASTHMATICS, *ADRENOCORTICAL hormones, *PUBLIC welfare, *MEDICAL care, *THERAPEUTICS, ALTERNATIVE treatment for asthma

العنوان البديل: Formoterol -- unique β2-mimetic drug that exert fast and long-lasting effects and is administered by Dry Powder Inhaler (Aeroliser) -- Oxodil -- product of Polpharma S.A.

المؤلفون: POLIWCZAK, ADAM RAFAŁ¹, BAŁA, AGNIESZKA¹, KOZIRÓG, MARZENA¹, ZABIELSKA, JUSTYNA¹, BRONCEL, MARLENA¹

المصدر: Problemy Terapii Monitorowanej. sep2008, Vol. 19 Issue 3, p251-260. 10p. 3 Black and White Photographs, 1 Diagram.

مصطلحات موضوعية: *FORMOTEROL, *DRUG administration, *INHALERS, *ASTHMA treatment

الشركة/الكيان: POLPHARMA SA